AT234914B - Process for the preparation of the new 6-morphine mononicotinic acid ester - Google Patents

Process for the preparation of the new 6-morphine mononicotinic acid ester

Info

Publication number
AT234914B
AT234914B AT248162A AT248162A AT234914B AT 234914 B AT234914 B AT 234914B AT 248162 A AT248162 A AT 248162A AT 248162 A AT248162 A AT 248162A AT 234914 B AT234914 B AT 234914B
Authority
AT
Austria
Prior art keywords
morphine
acid ester
new
preparation
mononicotinic
Prior art date
Application number
AT248162A
Other languages
German (de)
Inventor
Alfred Dr Pongratz
Konrad Lothar Dr Dr Zirm
Original Assignee
Lannacher Heilmittel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lannacher Heilmittel filed Critical Lannacher Heilmittel
Priority to AT248162A priority Critical patent/AT234914B/en
Application granted granted Critical
Publication of AT234914B publication Critical patent/AT234914B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

  

   <Desc/Clms Page number 1> 
 



  Verfahren zur Darstellung des neuen
6-Morphin-Mononicotinsäureesters 
 EMI1.1 
 

 <Desc/Clms Page number 2> 

 von Morphin mitkristallisieren aus Methanol/Wasser schmilzt der Ester bei   234 - 2350C : er   erweist sich als identisch mit der nach Beispiel 1 erhaltenen Verbindung. 



   Beispiel 3: 1,5 g 3,6-Morphin-bis-nicorinsäureesterbase werden in   30mlMethanolgelöstund   diese Lösung unter Rückfluss 14 h gekocht. Hierauf wird die etwas gelb gefärbte methylalkoholische Löi sung mit dem gleichen Volumen Wasser versetzt, worauf nach einigem Stehen der 6-Morpholin-mononi- cotinsäureester in einer Menge von 0, 9 g auskristallisiert.Das Reaktionsprodukt ist beinahe schmelzpunkt- rein (232 - 233, 5 C) und wird durch eine weitere Kristallisation aus verdünntem Methanol völlig rein er- halten : die Substanz erwies sich identisch mit der nach den Beispielen 1 und 2 erhaltenen Verbindung. 



   PATENTANSPRÜCHE : 
1. Verfahren zur Darstellung des neuen   6-Morphin-mononicotinsäureesters,   dadurch gekennzeichnet,   dass man aus   dem   3, 6-Morphin-bis-nicotinsäureester   oder seinen Salzen durch Hydrolyse in wässeriger bzw. schwachsaurer Lösung oder durch Erhitzen einer alkoholischen, vorzugsweise methylalkoholischen
Lösung des genannten Esters in Form der freien Base zum Sieden   einen Nicotinsäurerest   abspaltet.



   <Desc / Clms Page number 1>
 



  Procedure for representing the new
6-morphine mononicotinic acid ester
 EMI1.1
 

 <Desc / Clms Page number 2>

 co-crystallize from morphine from methanol / water, the ester melts at 234-2350C: it proves to be identical to the compound obtained according to Example 1.



   Example 3: 1.5 g of 3,6-morphine-bis-nicoric acid ester base are dissolved in 30 ml of methanol and this solution is boiled under reflux for 14 hours. The slightly yellow-colored methyl alcoholic solution is then treated with the same volume of water, whereupon the 6-morpholine-mononicotinic acid ester crystallizes out in an amount of 0.9 g after standing for a while. The reaction product is almost pure at the melting point (232-233, 5 C) and is obtained completely pure by further crystallization from dilute methanol: the substance was found to be identical to the compound obtained according to Examples 1 and 2.



   PATENT CLAIMS:
1. A process for the preparation of the new 6-morphine-mononicotinic acid ester, characterized in that the 3, 6-morphine-bis-nicotinic acid ester or its salts are hydrolyzed in an aqueous or weakly acidic solution or by heating an alcoholic, preferably methyl alcoholic
Solution of said ester in the form of the free base splits off a nicotinic acid residue at boiling point.

 

Claims (1)

2. Verfahren nach Anspruch 1, dadurch gekennzeichnet, dass man zur Abspaltung eines Nicotinsäure- restes eine verdünnte wässerige Lösung des 3, 6-Morphin-bis-nicotinsäureesters in Form seiner Salze, ins- besondere des Hydrochlorids, auf Temperaturen von 70 bis 100 C, vorzugsweise 80-90 C, erhitzt. EMI2.1 2. The method according to claim 1, characterized in that a dilute aqueous solution of the 3,6-morphine-bis-nicotinic acid ester in the form of its salts, in particular the hydrochloride, to temperatures of 70 to 100 ° C. is used to split off a nicotinic acid residue , preferably 80-90 C, heated. EMI2.1
AT248162A 1962-03-27 1962-03-27 Process for the preparation of the new 6-morphine mononicotinic acid ester AT234914B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT248162A AT234914B (en) 1962-03-27 1962-03-27 Process for the preparation of the new 6-morphine mononicotinic acid ester

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT248162A AT234914B (en) 1962-03-27 1962-03-27 Process for the preparation of the new 6-morphine mononicotinic acid ester

Publications (1)

Publication Number Publication Date
AT234914B true AT234914B (en) 1964-07-27

Family

ID=3535091

Family Applications (1)

Application Number Title Priority Date Filing Date
AT248162A AT234914B (en) 1962-03-27 1962-03-27 Process for the preparation of the new 6-morphine mononicotinic acid ester

Country Status (1)

Country Link
AT (1) AT234914B (en)

Similar Documents

Publication Publication Date Title
DE624230C (en) Process for the production of glutamine
DE952811C (en) Process for the production of ditetrazole or its salts
AT241697B (en) Process for the preparation of the new N-allylnormorphine-6-nicotinic acid ester
AT230882B (en) Process for the production of 6-aminochryses
AT146504B (en) Process for the preparation of amides of pyrazine monocarboxylic acid.
AT229496B (en) Process for the preparation of the new nicotinic acid ester of dihydroxycodeinone
DE432420C (en) Process for the preparation of N-methylsulphurous acid salts of secondary amines
AT210415B (en) Process for the preparation of new pyrrolidine derivatives
DE945926C (en) Process for the production of ªŠ-acetyl-lysine
DE739952C (en) Process for the production of ª ‡ -Piperidino-phenylessigsaeureamid
AT210573B (en) Process for the preparation of a new rescinnamine salt
AT225680B (en) Process for the production of new tertiary amines
AT160752B (en) Method for the preparation of pregnen- (4) -dione- (3.20).
AT203500B (en) Process for the preparation of new nicotinic acid hydrazide derivatives
DE872043C (en) Process for the production of reductic acid
CH249037A (en) Process for the preparation of a basic ester of a 1-aryl-cycloalkyl-1-carboxylic acid.
AT205041B (en) Process for the preparation of the new nicotinic acid ester of 1-oxyäthyltheobromine
CH373759A (en) Process for the production of a new heart-acting salt
CH260741A (en) Process for the preparation of a des-aza-adenine.
CH249041A (en) Process for the preparation of a basic ester of a 1-aryl-cycloalkyl-1-carboxylic acid.
CH310170A (en) Process for the preparation of a pharmaceutically active compound.
CH311409A (en) Process for the preparation of quinine gentisic acid.
CH242289A (en) Process for the preparation of a basic ester of a 1-aryl-cycloalkyl-1-carboxylic acid.
CH249039A (en) Process for the preparation of a basic ester of a 1-aryl-cycloalkyl-1-carboxylic acid.
CH254449A (en) Process for the preparation of a new oxyhydrophenanthrene derivative.